Until now, the occurrence of adverse reactions among individuals inoculated with identical vaccines has been ascribed to unpredictable stochastic processes. Recent advances in pharmacogenomics indicate that some features of host response to immunisation are influenced by genetic traits, henceforth predictable. The ability to predict the adverse reaction to vaccination would represent an important step towards the development of personalised vaccinology and could enhance public confidence in the safety of vaccines. Herein, we have reviewed all the available information on the association between genetic variants and the risk for healthy subjects to develop adverse reactions.The Pharmacogenomics Journal advance online publication, advance online publication, 7 October 2014; doi:10.1038/tpj.2014.57.

The first steps towards the era of personalised vaccinology: predicting adverse reactions / P. Pellegrino, F.S. Falvella, V. Perrone, C. Carnovale, T. Brusadelli, M. Pozzi, S. Antoniazzi, S. Cheli, C. Perrotta, E. Clementi, S. Radice. - In: PHARMACOGENOMICS JOURNAL. - ISSN 1470-269X. - 15:3(2015), pp. 284-287. [10.1038/tpj.2014.57]

The first steps towards the era of personalised vaccinology: predicting adverse reactions

P. Pellegrino;C. Carnovale;S. Antoniazzi;C. Perrotta;E. Clementi;
2015

Abstract

Until now, the occurrence of adverse reactions among individuals inoculated with identical vaccines has been ascribed to unpredictable stochastic processes. Recent advances in pharmacogenomics indicate that some features of host response to immunisation are influenced by genetic traits, henceforth predictable. The ability to predict the adverse reaction to vaccination would represent an important step towards the development of personalised vaccinology and could enhance public confidence in the safety of vaccines. Herein, we have reviewed all the available information on the association between genetic variants and the risk for healthy subjects to develop adverse reactions.The Pharmacogenomics Journal advance online publication, advance online publication, 7 October 2014; doi:10.1038/tpj.2014.57.
uman-papillomavirus vaccine; hepatitis-B vaccination; event reporting system; smallpox vaccination; measles vaccination; multiple-sclerosis; immunization; associations; cytokine; Asia
Settore BIO/14 - Farmacologia
2015
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/249049
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 16
social impact